American Oncology Network Profit Margin

American Oncology Network posts a profit margin of -0.44% as of December 2024. That compares with -0.73% in the prior-year period — up 40.7% year over year. That is below the sector sector average of 19.69%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, American Oncology Network's profit margin was -0.73%. The latest reading is -0.44% — a 40.7% year-over-year increase (period ending December 2024). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 19.69% is typical. American Oncology Network's -0.44% is lower that level. That is roughly 102.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

American Oncology Network's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -0.44% as of December 2024; use YoY and peer views to separate noise from signal.

Context for AONC's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.69%), and (3) consistency with growth and profitability. This page covers the first two; American Oncology Network's other metric pages and overview cover the third.